Table 3 Treatment regimen for patients with unfavorable subsets according to ST439
ST439 | ≤ 4.5 U/ml (n = 50) | > 4.5 U/ml (n = 24) | Total (n = 74) | p |
|---|---|---|---|---|
Lung, n (%) | 13 (26) | 6 (25) | 19 (26) | 1.0 |
Ovarian/Peritoneal, n (%) | 17 (34) | 1 (4) | 18 (24) | 0.004 |
CUP, n (%) | 9 (18) | 4 (17) | 13 (18) | 1.0 |
Breast, n (%) | 4 (8) | 2 (8) | 6 (8) | 1.0 |
Colorectal, n (%) | 1 (2) | 4 (17) | 5 (7) | 0.036 |
Ureteral/Kidney, n (%) | 2 (4) | 1 (4) | 3 (4) | 1.0 |
Biliary tract, n (%) | 1 (2) | 2 (8) | 3 (4) | 0.24 |
Salivary gland, n (%) | 0 | 3 (13) | 3 (4) | 0.031 |
Cervical, n (%) | 0 | 1 (4) | 1 (1) | 0.32 |
Nasopharyngeal, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |
Esophageal, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |
Skin, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |